Ery-uricase

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEry-uricase
Drug Alias NameRecombinant Uricase Enzyme Stimulator (EryDel)
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionUric acid stimulants
TargetsUric acid
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEryDel SpA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEryDel SpA
Active IndicationsN/A
Inactive IndicationsGout

Other Information

ATC CodeN/A
Related LinksN/A